QNRX vs. GSAT
QNRX (Quoin Pharmaceuticals Ltd DRC) and GSAT (Globalstar, Inc.) are both stocks. QNRX operates in Biotechnology (Healthcare), while GSAT operates in Telecom Services (Communication Services). Over the past 5 years, QNRX returned -85.89%/yr vs 24.62%/yr for GSAT. At a 0.12 correlation, their price movements are largely independent.
Performance
QNRX vs. GSAT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QNRX achieves a -69.44% return, which is significantly lower than GSAT's 30.75% return.
QNRX
- 1D
- -5.16%
- 1M
- -7.55%
- YTD
- -69.44%
- 6M
- -67.93%
- 1Y
- -49.31%
- 3Y*
- -73.86%
- 5Y*
- -85.89%
- 10Y*
- —
GSAT
- 1D
- -0.75%
- 1M
- -3.84%
- YTD
- 30.75%
- 6M
- 19.78%
- 1Y
- 239.91%
- 3Y*
- 76.29%
- 5Y*
- 24.62%
- 10Y*
- 16.97%
QNRX vs. GSAT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
QNRX Quoin Pharmaceuticals Ltd DRC | -69.44% | -36.64% | -86.73% | -71.21% | -93.76% | -78.94% | -2.70% | -78.86% | -70.00% | 126.54% |
GSAT Globalstar, Inc. | 30.75% | 96.59% | 6.70% | 45.86% | 14.66% | 242.59% | -34.88% | -18.71% | -51.17% | -17.09% |
Correlation
The correlation between QNRX and GSAT is 0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.05 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.20 |
Correlation (All Time) Calculated using the full available price history since Jul 29, 2016 | 0.12 |
The correlation between QNRX and GSAT shifts across timeframes, from 0.05 (1 year) to 0.20 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
QNRX:
$12.48M
GSAT:
$10.25B
QNRX:
-$13.39
GSAT:
-$0.11
QNRX:
1.42
GSAT:
29.90
QNRX:
$0.00
GSAT:
$283.02M
QNRX:
-$24.93K
GSAT:
$95.43M
QNRX:
-$17.28M
GSAT:
$69.56M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QNRX vs. GSAT — Risk / Return Rank
QNRX
GSAT
QNRX vs. GSAT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quoin Pharmaceuticals Ltd DRC (QNRX) and Globalstar, Inc. (GSAT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| QNRX | GSAT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -3.73 | ||
| Sortino ratioReturn per unit of downside risk | -2.87 | ||
| Omega ratioGain probability vs. loss probability | 1.09 | 1.49 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.61 | 9.10 | -9.71 |
| Martin ratioReturn relative to average drawdown | -0.98 | 22.24 | -23.21 |
Loading charts...
Drawdowns
QNRX vs. GSAT - Drawdown Comparison
The maximum QNRX drawdown since its inception was -100.00%, roughly equal to the maximum GSAT drawdown of -99.14%. Use the drawdown chart below to compare losses from any high point for QNRX and GSAT.
Loading charts...
Drawdown Indicators
| QNRX | GSAT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -99.14% | -0.86% |
Max Drawdown (1Y)Largest decline over 1 year | -81.17% | -26.53% | -54.64% |
Max Drawdown (3Y)Largest decline over 3 years | -98.68% | -50.72% | -47.96% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -67.54% | -32.46% |
Max Drawdown (10Y)Largest decline over 10 years | — | -89.34% | — |
Current DrawdownCurrent decline from peak | -100.00% | -69.63% | -30.37% |
Average DrawdownAverage peak-to-trough decline | -81.53% | -88.36% | +6.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 50.56% | 10.84% | +39.72% |
Volatility
QNRX vs. GSAT - Volatility Comparison
Quoin Pharmaceuticals Ltd DRC (QNRX) has a higher volatility of 23.57% compared to Globalstar, Inc. (GSAT) at 4.61%. This indicates that QNRX's price experiences larger fluctuations and is considered to be riskier than GSAT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QNRX | GSAT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 23.57% | 4.61% | +18.96% |
Volatility (6M)Calculated over the trailing 6-month period | 60.92% | 41.16% | +19.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 190.41% | 69.78% | +120.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 213.65% | 77.67% | +135.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 172.31% | 89.82% | +82.49% |
Dividends
QNRX vs. GSAT - Dividend Comparison
Neither QNRX nor GSAT has paid dividends to shareholders.
Financials
QNRX vs. GSAT - Financials Comparison
This section allows you to compare key financial metrics between Quoin Pharmaceuticals Ltd DRC and Globalstar, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
QNRX and GSAT have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QNRX has higher volatility (23.57%) compared to GSAT (4.61%). In terms of maximum drawdown, QNRX dropped -100.00% vs GSAT's -99.14%.
GSAT currently has the higher Sharpe Ratio (3.47 vs -0.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QNRX and GSAT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer